Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - DEPRECIATION & AMORTIZATION
Depreciation & Amortization EBS - Emergent BioSolutions Inc.
125 M
LAST VALUE
0.52%
2 YEAR CAGR
15.00%
5 YEAR CAGR
20.77%
10 YEAR CAGR